Literature DB >> 23383651

First-episode acute and transient psychotic disorder in Latvia: a 6-year follow-up study.

Marija Rusaka1, Elmārs Rancāns.   

Abstract

BACKGROUND: Acute and transient psychotic disorder (ATPD; F23, ICD-10) is an acute, short-lived psychosis, which has variable prevalence worldwide and has not been extensively studied. AIMS: To explore the first episode of ATPD in patients in Latvia by describing the clinical features, analyzing the longitudinal changes of diagnosis and associated socio-demographic characteristics.
MATERIAL AND METHODS: Retrospective chart review of all first-time hospitalized patients fulfilling the ICD-10 criteria for ATPD treated at the Riga Centre of Psychiatry and Addiction Disorders, Latvia, during a 3-year period. Patients were followed-up and assessed using standardized instruments.
RESULTS: During a 3-year period, 294 patients were first-time hospitalized with a ATPD diagnosis; 54% were women. The average age at first psychotic episode was 35.7 ± 12.3 years for women, and 30.0 ± 10.8 years for men (P < 0.0001). Over an average of 5.6 years follow-up period, 51% of patients were not re-hospitalized. Later diagnosis was changed to schizophrenia in 73% of the re-hospitalized patients, mostly within the first 2 years of illness. The overall stability rate of ATPD diagnosis reached 58%. Typical polymorphic symptomatology, abrupt onset (i.e. within 48 h), less frequent anxiety, but more frequent hallucinations were observed in ATPD patients that later developed schizophrenia (P < 0.05). Stressful life events in the 6 months prior to the first episode were found in 44% of patients.
CONCLUSIONS: Combining these assessments from first-episode ATPD patients in Latvia, with data from other countries may help to predict the development of disease and provide the possible basis for potential changes to ICD-11.

Entities:  

Mesh:

Year:  2013        PMID: 23383651     DOI: 10.3109/08039488.2012.761726

Source DB:  PubMed          Journal:  Nord J Psychiatry        ISSN: 0803-9488            Impact factor:   2.202


  7 in total

Review 1.  Acute and Transient Psychotic Disorders: Newer Understanding.

Authors:  Savita Malhotra; Swapnajeet Sahoo; Srinivas Balachander
Journal:  Curr Psychiatry Rep       Date:  2019-11-04       Impact factor: 5.285

2.  The predictive validity and outcome of ICD-10 and DSM-5 short-lived psychotic disorders: a review and meta-analysis.

Authors:  Augusto Castagnini; Leslie Foldager; Ernesto Caffo; German E Berrios
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2022-01-06       Impact factor: 5.760

3.  Clinical outcomes in brief psychotic episodes: a systematic review and meta-analysis.

Authors:  U Provenzani; G Salazar de Pablo; M Arribas; F Pillmann; P Fusar-Poli
Journal:  Epidemiol Psychiatr Sci       Date:  2021-11-04       Impact factor: 7.818

4.  Variations in incidence and age of onset of acute and transient psychotic disorders.

Authors:  Augusto Castagnini; Leslie Foldager
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2013-06-20       Impact factor: 4.328

5.  A prospective follow-up study of first-episode acute transient psychotic disorder in Latvia.

Authors:  Marija Rusaka; Elmārs Rancāns
Journal:  Ann Gen Psychiatry       Date:  2014-02-06       Impact factor: 3.455

6.  Transition of Substance-Induced, Brief, and Atypical Psychoses to Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Benjamin Murrie; Julia Lappin; Matthew Large; Grant Sara
Journal:  Schizophr Bull       Date:  2020-04-10       Impact factor: 9.306

7.  Clinical characterization of brief psychotic disorders triggered by the COVID-19 pandemic: a multicenter observational study.

Authors:  María José Valdés-Florido; Álvaro López-Díaz; Fernanda Jazmín Palermo-Zeballos; Nathalia Garrido-Torres; Paula Álvarez-Gil; Iván Martínez-Molina; Victoria Eugenia Martín-Gil; Elena Ruiz-Ruiz; Macarena Mota-Molina; María Paz Algarín-Moriana; Antonio Hipólito Guzmán-Del Castillo; Ángela Ruiz-Arcos; Rafael Gómez-Coronado; Sara Galiano-Rus; Alfonso Rosa-Ruiz; Juan Luis Prados-Ojeda; Luis Gutierrez-Rojas; Benedicto Crespo-Facorro; Miguel Ruiz-Veguilla
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-04-03       Impact factor: 5.270

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.